Search Results

There are 6667 results for: content related to: How to optimize HCV therapy in genotype 1 patients: predictors of response

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  3. You have free access to this content
    Viral Hepatitis: Epidemiology and Diagnosis

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1276A–1309A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26884

  4. You have free access to this content
    Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 850–860, Calogero Cammà, Salvatore Petta, Marco Enea, Raffaele Bruno, Fabrizio Bronte, Vincenza Capursi, Americo Cicchetti, Giorgio L. Colombo, Vito Di Marco, Antonio Gasbarrini, Antonio Craxì and on behalf of the WEF Study Group

    Version of Record online : 12 JUL 2012, DOI: 10.1002/hep.25734

  5. You have free access to this content
    The impact of hepatitis C virus outside the liver: Evidence from Asia

    Liver International

    Volume 37, Issue 2, February 2017, Pages: 159–172, Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young-Suk Lim, Ming-Lung Yu, Norifumi Kawada, Yock Young Dan, Craig Brooks-Rooney, Francesco Negro and Mario U. Mondelli

    Version of Record online : 10 NOV 2016, DOI: 10.1111/liv.13272

  6. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  7. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 691–701, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Yuya Seko, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Rie Mineta, Sachiyo Watahiki, Mariko Kobayashi, Yoshiyuki Nakayasu, Hidetaka Tsuda, Keiji Aoki, Ichimaro Yamada and Hiromitsu Kumada

    Version of Record online : 29 NOV 2012, DOI: 10.1111/hepr.12009

  8. You have free access to this content
    HCV: Pathogenesis

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1168A–1190A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26881

  9. You have free access to this content
    Viral Hepatitis

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 151–177,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_14

  10. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study

    Liver International

    Volume 35, Issue 10, October 2015, Pages: 2246–2255, Yeon Seok Seo, Moon Young Kim, Seung Up Kim, Bae Si Hyun, Jae Young Jang, Jin Woo Lee, Jung Il Lee, Sang Jun Suh, Soo Young Park, Hana Park, Eun Uk Jung, Byung Seok Kim, In Hee Kim, Tae Hee Lee, Soon Ho Um, Kwang-Hyub Han, Sang Gyune Kim, Soon Koo Paik, Jong Young Choi, Soung Won Jeong, Young Joo Jin, Kwan Sik Lee, Hyung Joon Yim, Won Young Tak, Seong Gyu Hwang, Youn Jae Lee, Chang Hyeong Lee, Dae-Ghon Kim, Young Woo Kang, Young Seok Kim and The Korean Transient Elastography Study Group

    Version of Record online : 26 FEB 2015, DOI: 10.1111/liv.12808

  11. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  12. Preliminary evidence of sustained expression of angiopoietin-2 during monocyte differentiation in chronic hepatitis C

    Liver International

    Volume 33, Issue 6, July 2013, Pages: 864–870, Yolanda Rodríguez-Muñoz, Samuel Martín-Vílchez, Rosario López-Rodríguez, Ángel Hernández-Bartolomé, Luisa García-Buey, María J. Borque, Ricardo Moreno-Otero and Paloma Sanz-Cameno

    Version of Record online : 19 FEB 2013, DOI: 10.1111/liv.12125

  13. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 429–437, Mette J. Nielsen, Sanne S. Veidal, Morten A. Karsdal, Diana J. Ørsnes-Leeming, Ben Vainer, Stephen D. Gardner, Robert Hamatake, Zachary D. Goodman, Detlef Schuppan and Keyur Patel

    Version of Record online : 28 OCT 2014, DOI: 10.1111/liv.12700

  14. You have free access to this content
    Current and future HCV therapy: do we still need other anti-HCV drugs?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 4–10, Salvatore Petta and Antonio Craxì

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12714

  15. You have free access to this content
    Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 59, Issue 5, May 2014, Pages: 1692–1705, Salvatore Petta, Giuseppe Cabibbo, Marco Enea, Fabio Salvatore Macaluso, Antonella Plaia, Raffaele Bruno, Antonio Gasbarrini, Antonio Craxì, Calogero Cammà and on Behalf of the WEF Study Group

    Version of Record online : 1 APR 2014, DOI: 10.1002/hep.27010

  16. Significance of miRNA-122 in chronic hepatitis C patients with serotype 1 on interferon therapy

    Hepatology Research

    Volume 45, Issue 1, January 2015, Pages: 88–96, Yasuhiro Kamo, Tatsuki Ichikawa, Hisamitsu Miyaaki, Shinjirou Uchida, Tohei Yamaguchi, Hidetaka Shibata, Takuya Honda, Naota Taura, Hajime Isomoto, Fuminao Takeshima and Kazuhiko Nakao

    Version of Record online : 27 JUN 2014, DOI: 10.1111/hepr.12317

  17. Efficacy and safety of telaprevir with natural human interferon-β and ribavirin in Japanese chronic hepatitis C patients with depression

    Hepatology Research

    Hiromitsu Kumada, Satoshi Mochida, Makoto Nakamuta, Fumitaka Suzuki, Takashi Yagi, Ryuji Takasaki, Masao Okai, Naohiro Kamiya, Yasushi Okada, Saya Hirota, Madori Orihashi, Miyoko Ochi and Kazuaki Chayama

    Version of Record online : 19 JUL 2017, DOI: 10.1111/hepr.12914

  18. Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy

    Liver International

    Volume 34, Issue 7, August 2014, Pages: 1018–1024, James F. Crismale, Valérie Martel-Laferrière, Kian Bichoupan, Emily Schonfeld, Alexis Pappas, Christina Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano, Ponni V. Perumalswami, Meena Bansal, Douglas T. Dieterich and Andrea D. Branch

    Version of Record online : 25 OCT 2013, DOI: 10.1111/liv.12342

  19. You have free access to this content
    A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E386–E396, Noritomo Shimada, Akihito Tsubota, Masanori Atsukawa, Hiroshi Abe, Tatsuya Ide, Koichi Takaguchi, Yoshimichi Chuganji, Hidenori Toyoda, Kai Yoshizawa, Makiko Ika, Yoshiyuki Sato, Keizo Kato, Takashi Kumada, Choitsu Sakamoto, Yoshio Aizawa and Michio Sata

    Version of Record online : 15 APR 2014, DOI: 10.1111/hepr.12323

  20. You have free access to this content
    HCV: Virology

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 926A–943A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26868